Repurposing the Fda Approved Drug Pyrvinium Pamoate to Target Hur in Pancreatic Ductal Adenocarcinoma

Authors

• Charles Yeo

Publication/Presentation Date

5-2019

Volume

156

Issue

6

First Page

1376

Last Page

1377

Published In/Presented At

10.1016/S0016-5085(19)40466-6

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

Department(s)

Administration and Leadership

Document Type

Article